The Beauty Health Company (SKIN) 8-K BeautyHealth Reports Third Quarter 2022 Financial Results

°

✓ ✓ ✓ ✓ ✓

∆ ∆ ∆

Reconciliation of net income to adjusted EBITDA ($mm) Net sales Net income (loss) Adjusted to exclude the following: Change in FV of warrant liability Change in FV of earn-out shares liability Amortization expense Gain / loss on disposal of assets Stock-based compensation expense Other expense (income) Management fees1 Transaction related costs2 Other non-recurring and one-time fees3 Aaaregate adjustment for income taxes Adiusted net income (loss) Depreciation expense Interest expense Foreign currency (gain) loss, net Remaininq benefit for income taxes Adjusted EBITDA Adjusted EBITDA margin Three months ended September 30, 2022 2021 _ $_8_8:8_ $68.1 $0.1 ($215.1) (4.3) 3.9 4.7 7.4 (2.5) 2.6 (4.0) $8.0 2.0 3.4 (0.0) 3.2 $16.5 18.6% 199.3 10.6 3.5 5.1 (O.O) 1.2 0.5 (2.4) $2.5 1.0 0.5 0.4 1.3 $5.8 8.5% Year ended 12/31/21 $260.1 ($375.1) 277.3 47.1 13.3 12.4 4.5 0.2 34.9 4.0 (14.1) $4.5 4.5 11.8 0.1 11.8 $32.7 12.6% Note: Figures may not foot due to rounding; Periods for the three months ended September 30, 2022 and September 30, 2021 are unaudited. l. Represents quarterly management fees paid to the majority shareholder of Hydra Facial based on a pre-determined formula. Following the Business Combination, these fees are no longer paid. 2. For the three months ended September 30, 2021, such amount primarily represent direct costs incurred in relation to potential acquisitions. For the year ended December 31, 2021 such amount primarily represents direct costs incurred with the Business Combination, including $21.0 million paid to the former owner of HydraFacial, and to prepare HydraFacial to be marketed for sale by HydraFacial's shareholders in previous periods. 3. For the three months ended September 30, 2022, such costs primarily represent a write-off related to the discontinued Glow 8 Go pilot program. For the three months ended September 30, 2021, such costs primarily represent one-time retention awards related to the distributor acquisitions. For the year ended December 31, 2021, such costs primarily represent recruiting fees for executive officers, severance and one-time retention awards related to the distributor acquisitions. 35 + BEAUTYHEALTH'"